Switching Study of Kidney Transplant Patients With Tremor to LCP-Tacro (STRATO)
Public ClinicalTrials.gov record NCT01438710. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate and measure symptomatic hand tremor in stable kidney transplant subjects on Prograf or generic tacrolimus maintenance therapy at baseline (pre-conversion) and following conversion to LCP-Tacro. This study will also evaluate the safety of LCP-Tacro compared with Prograf or generic tacrolimus
Study identification
- NCT ID
- NCT01438710
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 44 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years to 65 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Dec 2011 (Type not available)
- Primary completion
- Aug 2012 (Actual)
- Completion
- Jul 2015 (Actual)
- Last update posted
- Oct 1, 2015
2011 – 2015
United States locations
- U.S. sites
- 10
- U.S. states
- 9
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Investigative Site 006 | Los Angeles | California | 90057 | — |
| Clinical Investigative Site 1049 | San Diego | California | 92123 | — |
| Clinical Investigative Site 007 | Aurora | Colorado | 80045 | — |
| Clinical Investigative Site 005 | New Haven | Connecticut | 06520 | — |
| Clinical Investigative Site 004 | Lexington | Kentucky | 40536 | — |
| Clinical Investigative Site 008 | Minneapolis | Minnesota | 55455 | — |
| Clinical Investigative Site 003 | St Louis | Missouri | 63110 | — |
| Clinical Investigative Site 002 | Oklahoma City | Oklahoma | 73112 | — |
| Clinical Investigative Site 009 | Nashiville | Tennessee | 37232 | — |
| Clinical Investigative Site 012 | Dallas | Texas | 75246 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01438710, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Oct 1, 2015 · Synced Oct 22, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01438710 live on ClinicalTrials.gov.